-transparent.png){kind=logo}
In several studies on patients with rheumatoid arthritis, an association of bone loss with a persistently high disease activity has been found. The aim of our study was to investigate the relation between disease activity and serum levels of vitamin D metabolites, parathyroid hormone (PTH), and parameters of bone turnover in patients with rheumatoid arthritis. A total of 96 patients (83 women and 13 men) were divided into three groups according to disease activity measured by serum levels of C-reactive protein (CRP). In the whole group, serum levels of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) (P < 0.001) and PTH (P < 0.05) were negatively correlated to disease activity. The urinary excretion of collagen crosslinks--pyridinoline (Pyd) (P < 0.001) and deoxypyridinoline (Dpd) (P < 0.05)--showed a positive correlation with disease activity. The inverse correlation between serum 1,25(OH)2D3 and disease activity was separately evident in patients with (P < 0.001) and without (P < 0.01) glucocorticoid treatment, in pre- (P < 0.01) and postmenopausal (P < 0.001) women, and in men (P < 0.01). 1,25(OH)2D3 and PTH serum levels were positively correlated to serum bone alkaline phosphatase (ALP) (P < 0.01). The results indicate that high disease activity in patients with rheumatoid arthritis is associated with an alteration in vitamin D metabolism and increased bone resorption. The decrease of 1,25(OH)2D3 levels in these patients may contribute to a negative calcium balance and inhibition of bone formation. Furthermore, low levels of 1,25(OH)2D3 as an endogenous immunomodulator suppressing activated T cells and the proliferation of cells may accelerate the arthritic process in rheumatoid arthritis.
P Oelzner, and
A Müller, and
F Deschner, and
M Hüller, and
K Abendroth, and
G Hein, and
G Stein
April 2012,
Endocrine regulations,
P Oelzner, and
A Müller, and
F Deschner, and
M Hüller, and
K Abendroth, and
G Hein, and
G Stein
January 2023,
Clinical medicine insights. Arthritis and musculoskeletal disorders,
P Oelzner, and
A Müller, and
F Deschner, and
M Hüller, and
K Abendroth, and
G Hein, and
G Stein
September 2021,
Cureus,
P Oelzner, and
A Müller, and
F Deschner, and
M Hüller, and
K Abendroth, and
G Hein, and
G Stein
December 2001,
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,
P Oelzner, and
A Müller, and
F Deschner, and
M Hüller, and
K Abendroth, and
G Hein, and
G Stein
June 1987,
Clinical rheumatology,
P Oelzner, and
A Müller, and
F Deschner, and
M Hüller, and
K Abendroth, and
G Hein, and
G Stein
April 2018,
Nordic journal of psychiatry,
P Oelzner, and
A Müller, and
F Deschner, and
M Hüller, and
K Abendroth, and
G Hein, and
G Stein
September 2020,
Archives of rheumatology,
P Oelzner, and
A Müller, and
F Deschner, and
M Hüller, and
K Abendroth, and
G Hein, and
G Stein
March 2013,
African health sciences,
P Oelzner, and
A Müller, and
F Deschner, and
M Hüller, and
K Abendroth, and
G Hein, and
G Stein
January 2006,
Clinical and experimental rheumatology,
P Oelzner, and
A Müller, and
F Deschner, and
M Hüller, and
K Abendroth, and
G Hein, and
G Stein
March 2019,
The Journal of steroid biochemistry and molecular biology,
